These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 28763646
1. Design, synthesis and biological evaluation of 4-anilinoquinoline derivatives as novel potent tubulin depolymerization agents. Zhou Y, Yan W, Cao D, Shao M, Li D, Wang F, Yang Z, Chen Y, He L, Wang T, Shen M, Chen L. Eur J Med Chem; 2017 Sep 29; 138():1114-1125. PubMed ID: 28763646 [Abstract] [Full Text] [Related]
2. Design, synthesis and biological evaluation of 2-phenylquinoline-4-carboxamide derivatives as a new class of tubulin polymerization inhibitors. Zhu L, Luo K, Li K, Jin Y, Lin J. Bioorg Med Chem; 2017 Nov 01; 25(21):5939-5951. PubMed ID: 28988750 [Abstract] [Full Text] [Related]
3. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors. Cao D, Liu Y, Yan W, Wang C, Bai P, Wang T, Tang M, Wang X, Yang Z, Ma B, Ma L, Lei L, Wang F, Xu B, Zhou Y, Yang T, Chen L. J Med Chem; 2016 Jun 23; 59(12):5721-39. PubMed ID: 27213819 [Abstract] [Full Text] [Related]
4. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L. Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450 [Abstract] [Full Text] [Related]
5. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors. Mirzaei S, Eisvand F, Hadizadeh F, Mosaffa F, Ghasemi A, Ghodsi R. Bioorg Chem; 2020 May 01; 98():103711. PubMed ID: 32179282 [Abstract] [Full Text] [Related]
6. 2-Anilino-3-Aroylquinolines as Potent Tubulin Polymerization Inhibitors. Srikanth PS, Nayak VL, Suresh Babu K, Kumar GB, Ravikumar A, Kamal A. ChemMedChem; 2016 Sep 20; 11(18):2050-62. PubMed ID: 27465681 [Abstract] [Full Text] [Related]
7. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation. Hagras M, El Deeb MA, Elzahabi HSA, Elkaeed EB, Mehany ABM, Eissa IH. J Enzyme Inhib Med Chem; 2021 Dec 20; 36(1):640-658. PubMed ID: 33588683 [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of quinoline analogues of flavones as potential anticancer agents and tubulin polymerization inhibitors. Shobeiri N, Rashedi M, Mosaffa F, Zarghi A, Ghandadi M, Ghasemi A, Ghodsi R. Eur J Med Chem; 2016 May 23; 114():14-23. PubMed ID: 26974371 [Abstract] [Full Text] [Related]
9. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities. Ren Y, Ruan Y, Cheng B, Li L, Liu J, Fang Y, Chen J. Bioorg Med Chem; 2021 Sep 15; 46():116376. PubMed ID: 34455231 [Abstract] [Full Text] [Related]
10. Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors. Zhang QW, Ye ZD, Shen C, Tie HX, Wang L, Shi L. J Enzyme Inhib Med Chem; 2019 Dec 15; 34(1):124-133. PubMed ID: 30422010 [Abstract] [Full Text] [Related]
11. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site. Wang G, Peng Z, Zhang J, Qiu J, Xie Z, Gong Z. Bioorg Chem; 2018 Aug 15; 78():332-340. PubMed ID: 29627654 [Abstract] [Full Text] [Related]
12. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors. Wang G, Peng F, Cao D, Yang Z, Han X, Liu J, Wu W, He L, Ma L, Chen J, Sang Y, Xiang M, Peng A, Wei Y, Chen L. Bioorg Med Chem; 2013 Nov 01; 21(21):6844-54. PubMed ID: 23993668 [Abstract] [Full Text] [Related]
13. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety. Li S, Huang Q, Liu Y, Zhang X, Liu S, He C, Gong P. Eur J Med Chem; 2013 Jun 01; 64():62-73. PubMed ID: 23644189 [Abstract] [Full Text] [Related]
14. Design and synthesis of 4-morpholino-6-(1,2,3,6-tetrahydropyridin-4-yl)-N-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine analogues as tubulin polymerization inhibitors. Narva S, Chitti S, Amaroju S, Bhattacharjee D, Rao BB, Jain N, Alvala M, Sekhar KVGC. Bioorg Med Chem Lett; 2017 Aug 15; 27(16):3794-3801. PubMed ID: 28684120 [Abstract] [Full Text] [Related]
15. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S, An B, Li Y, Luo X, Li X, Jia X. Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1769-1775. PubMed ID: 29673981 [Abstract] [Full Text] [Related]
16. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors. Berger DM, Dutia M, Birnberg G, Powell D, Boschelli DH, Wang YD, Ravi M, Yaczko D, Golas J, Lucas J, Boschelli F. J Med Chem; 2005 Sep 22; 48(19):5909-20. PubMed ID: 16161995 [Abstract] [Full Text] [Related]
17. Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors. Yang H, An B, Li X, Zeng W. Bioorg Med Chem Lett; 2018 Oct 01; 28(18):3057-3063. PubMed ID: 30093295 [Abstract] [Full Text] [Related]
18. A fluorine scan of a tubulin polymerization inhibitor isocombretastatin A-4: Design, synthesis, molecular modelling, and biological evaluation. Naret T, Bignon J, Bernadat G, Benchekroun M, Levaique H, Lenoir C, Dubois J, Pruvost A, Saller F, Borgel D, Manoury B, Leblais V, Darrigrand R, Apcher S, Brion JD, Schmitt E, Leroux FR, Alami M, Hamze A. Eur J Med Chem; 2018 Jan 01; 143():473-490. PubMed ID: 29202409 [Abstract] [Full Text] [Related]
19. Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC. Jia M, Pei Y, Li N, Zhang Y, Song J, Niu JB, Yang H, Zhang S, Sun M. Eur J Med Chem; 2024 Sep 05; 275():116611. PubMed ID: 38901104 [Abstract] [Full Text] [Related]
20. 2-Anilinoquinoline based arylamides as broad spectrum anticancer agents with B-RAFV600E/C-RAF kinase inhibitory effects: Design, synthesis, in vitro cell-based and oncogenic kinase assessments. El-Damasy AK, Haque MM, Park JW, Shin SC, Lee JS, EunKyeong Kim E, Keum G. Eur J Med Chem; 2020 Dec 15; 208():112756. PubMed ID: 32942186 [Abstract] [Full Text] [Related] Page: [Next] [New Search]